Granite Bio
↗Basel, Switzerland
Granite Bio is a clinical-stage biotechnology company based in Basel, Switzerland, developing first-in-class therapeutic antibodies targeting the root causes of inflammatory, autoimmune, and fibrotic diseases. Founded in 2021 by Professor Matthias Mack, the company applies innovative immunology approaches to selectively deplete pathogenic cells while preserving tissue-resident immune populations. Emerged from stealth in April 2025 with a differentiated pipeline of monocyte-depleting and cytokine-targeting antibodies.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Immunology/Autoimmune Therapeutics
SIZE & FINANCIALS
Employees:51-200
Revenue:$0-5M
Founded:2021
Ownership:private
Status:operating
FUNDING
Stage:Series B
Total Raised:$100M
Investors:Versant Ventures, Novartis Venture Fund, Forbion, Sanofi Ventures
PIPELINE
Stage:Phase 1
Lead Drug Stage:Phase 1b (Expected 2025)
Modalities:Monoclonal Antibodies (mAb)
Active Trials:2
Trial Phases:Phase 1: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Versant Ventures (Ridgeline Discovery Engine collaboration), Roche (scientific talent/expertise)
COMPETITION
Position:Emerging
Competitors:ADMA Biologics, BioNTech, Kymeratx, 385+ additional companies in immunology/autoimmune space
LEADERSHIP
Key Executives:
Patrick Loustau - President and CEO
Dominik Hartl, M.D. - Chief Medical Officer
Gijs van den Brink, M.D., Ph.D. - Chief Scientific Officer
Eliot Forster - Board Chair
Sara Belli - Head of Clinical Pharmacology
Scientific Founders:Matthias Mack (University of Regensburg)
Board Members:Eliot Forster (Chair)
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Granite Bio and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Granite Bio. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.